AGENUS REPORTS MORE THAN HALF OF PATIENTS WITH REFRACTORY MSS METASTATIC COLORECTAL CANCER ACHIEVED LONG-TERM SURVIVAL FOLLOWING BOT+BAL TREATMENT AT SITC 2026

Reuters · 2d ago

Please log in to view news